JP2012532619A

JP2012532619A - Ｔｎｆｒ１を部分的に阻害するためのアンタゴニスト、用途および方法

Ｔｎｆｒ１を部分的に阻害するためのアンタゴニスト、用途および方法 Download PDF

Info

Publication number: JP2012532619A
Authority: JP; Japan
Prior art keywords: dom1h; tnfr1; antagonist; tnfα; dab
Prior art date: 2009-07-16
Legal status : Pending

Application number

JP2012520015A

Other languages

English (en)

Japanese (ja)

Other versions

JP2012532619A5 (cg-RX-API-DMAC7.html

Inventor

アラートストゥープ，アドリアーン

Current Assignee

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date

2009-07-16

Filing date

2010-07-14

Publication date

2012-12-20

2010-07-14 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2012-12-20 Publication of JP2012532619A publication Critical patent/JP2012532619A/ja

2013-08-29 Publication of JP2012532619A5 publication Critical patent/JP2012532619A5/ja

Status Pending legal-status Critical Current

Links

102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 title claims abstract description 420
101710187743 Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 title claims abstract description 360
239000005557 antagonist Substances 0.000 title claims abstract description 346
238000000034 method Methods 0.000 title claims abstract description 101
230000002401 inhibitory effect Effects 0.000 title claims description 37
230000001404 mediated effect Effects 0.000 claims abstract description 73
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 65
201000010099 disease Diseases 0.000 claims abstract description 61
206010003246 arthritis Diseases 0.000 claims abstract description 27
230000004968 inflammatory condition Effects 0.000 claims abstract description 10
208000011231 Crohn disease Diseases 0.000 claims abstract description 7
201000004681 Psoriasis Diseases 0.000 claims abstract description 6
230000027455 binding Effects 0.000 claims description 214
238000009739 binding Methods 0.000 claims description 213
108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 178
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 178
238000003556 assay Methods 0.000 claims description 147
125000003275 alpha amino acid group Chemical group 0.000 claims description 130
108060003951 Immunoglobulin Proteins 0.000 claims description 122
102000018358 immunoglobulin Human genes 0.000 claims description 122
150000007523 nucleic acids Chemical class 0.000 claims description 79
102000005962 receptors Human genes 0.000 claims description 76
108020003175 receptors Proteins 0.000 claims description 76
102000039446 nucleic acids Human genes 0.000 claims description 75
108020004707 nucleic acids Proteins 0.000 claims description 75
101100425753 Homo sapiens TNFRSF1A gene Proteins 0.000 claims description 61
101100425754 Mus musculus Tnfrsf1a gene Proteins 0.000 claims description 41
230000036963 noncompetitive effect Effects 0.000 claims description 37
239000013598 vector Substances 0.000 claims description 30
230000011664 signaling Effects 0.000 claims description 28
239000003112 inhibitor Substances 0.000 claims description 27
239000003814 drug Substances 0.000 claims description 24
101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 claims description 23
102000057041 human TNF Human genes 0.000 claims description 23
101000648740 Mus musculus Tumor necrosis factor Proteins 0.000 claims description 21
208000022559 Inflammatory bowel disease Diseases 0.000 claims description 17
238000004519 manufacturing process Methods 0.000 claims description 16
206010039073 rheumatoid arthritis Diseases 0.000 claims description 12
230000001684 chronic effect Effects 0.000 claims description 8
239000003085 diluting agent Substances 0.000 claims description 6
239000008194 pharmaceutical composition Substances 0.000 claims description 6
206010009900 Colitis ulcerative Diseases 0.000 claims description 4
201000006704 Ulcerative Colitis Diseases 0.000 claims description 4
239000003937 drug carrier Substances 0.000 claims description 4
239000000546 pharmaceutical excipient Substances 0.000 claims description 4
206010002556 Ankylosing Spondylitis Diseases 0.000 claims description 3
208000003456 Juvenile Arthritis Diseases 0.000 claims description 3
206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims description 3
230000005540 biological transmission Effects 0.000 claims description 3
208000019069 chronic childhood arthritis Diseases 0.000 claims description 3
201000002215 juvenile rheumatoid arthritis Diseases 0.000 claims description 3
201000008482 osteoarthritis Diseases 0.000 claims description 2
108020003519 protein disulfide isomerase Proteins 0.000 abstract description 48
239000000203 mixture Substances 0.000 abstract description 47
238000011282 treatment Methods 0.000 abstract description 27
230000002685 pulmonary effect Effects 0.000 abstract description 21
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract description 13
230000002265 prevention Effects 0.000 abstract description 13
208000006673 asthma Diseases 0.000 abstract description 9
238000009472 formulation Methods 0.000 abstract description 7
101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 abstract description 6
101000883685 Heliothis virescens 60 kDa chaperonin, mitochondrial Proteins 0.000 abstract description 2
101001082060 Homo sapiens Interferon-induced protein with tetratricopeptide repeats 3 Proteins 0.000 abstract description 2
101000752245 Homo sapiens Rho guanine nucleotide exchange factor 5 Proteins 0.000 abstract description 2
102100021688 Rho guanine nucleotide exchange factor 5 Human genes 0.000 abstract description 2
101000620888 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Repressible acid phosphatase Proteins 0.000 abstract description 2
206010054094 Tumour necrosis Diseases 0.000 abstract description 2
230000000259 anti-tumor effect Effects 0.000 abstract description 2
210000004027 cell Anatomy 0.000 description 164
108090000765 processed proteins & peptides Proteins 0.000 description 143
102000004196 processed proteins & peptides Human genes 0.000 description 113
239000003446 ligand Substances 0.000 description 98
229920001184 polypeptide Polymers 0.000 description 86
108090000623 proteins and genes Proteins 0.000 description 71
241000699666 Mus <mouse, genus> Species 0.000 description 69
235000001014 amino acid Nutrition 0.000 description 61
241000282414 Homo sapiens Species 0.000 description 60
102000007562 Serum Albumin Human genes 0.000 description 59
108010071390 Serum Albumin Proteins 0.000 description 59
102000004169 proteins and genes Human genes 0.000 description 57
230000005764 inhibitory process Effects 0.000 description 55
150000001413 amino acids Chemical class 0.000 description 51
235000018102 proteins Nutrition 0.000 description 51
102000004890 Interleukin-8 Human genes 0.000 description 47
108090001007 Interleukin-8 Proteins 0.000 description 47
229940096397 interleukin-8 Drugs 0.000 description 47
XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 47
230000000694 effects Effects 0.000 description 40
102000008100 Human Serum Albumin Human genes 0.000 description 39
108091006905 Human Serum Albumin Proteins 0.000 description 39
239000012634 fragment Substances 0.000 description 39
102000009027 Albumins Human genes 0.000 description 36
108010088751 Albumins Proteins 0.000 description 36
102000035195 Peptidases Human genes 0.000 description 36
108091005804 Peptidases Proteins 0.000 description 36
239000004365 Protease Substances 0.000 description 36
230000004927 fusion Effects 0.000 description 33
239000002773 nucleotide Substances 0.000 description 33
125000003729 nucleotide group Chemical group 0.000 description 33
101100112922 Candida albicans CDR3 gene Proteins 0.000 description 31
241000699670 Mus sp. Species 0.000 description 31
230000014509 gene expression Effects 0.000 description 29
229920001223 polyethylene glycol Polymers 0.000 description 29
238000012384 transportation and delivery Methods 0.000 description 29
239000000427 antigen Substances 0.000 description 28
102000036639 antigens Human genes 0.000 description 28
108091007433 antigens Proteins 0.000 description 28
239000000178 monomer Substances 0.000 description 23
102100035361 Cerebellar degeneration-related protein 2 Human genes 0.000 description 22
101000737796 Homo sapiens Cerebellar degeneration-related protein 2 Proteins 0.000 description 22
239000000243 solution Substances 0.000 description 21
241000588724 Escherichia coli Species 0.000 description 20
230000000875 corresponding effect Effects 0.000 description 19
230000028327 secretion Effects 0.000 description 19
238000001525 receptor binding assay Methods 0.000 description 18
210000002966 serum Anatomy 0.000 description 18
206010035664 Pneumonia Diseases 0.000 description 17
230000002860 competitive effect Effects 0.000 description 17
241000282567 Macaca fascicularis Species 0.000 description 16
102000004142 Trypsin Human genes 0.000 description 16
108090000631 Trypsin Proteins 0.000 description 16
238000004458 analytical method Methods 0.000 description 16
238000001727 in vivo Methods 0.000 description 16
230000001965 increasing effect Effects 0.000 description 16
230000002829 reductive effect Effects 0.000 description 16
239000012588 trypsin Substances 0.000 description 16
238000012512 characterization method Methods 0.000 description 15
238000011534 incubation Methods 0.000 description 15
238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 15
NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical group COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 14
241000124008 Mammalia Species 0.000 description 14
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
238000001514 detection method Methods 0.000 description 14
238000010494 dissociation reaction Methods 0.000 description 14
230000005593 dissociations Effects 0.000 description 14
238000006386 neutralization reaction Methods 0.000 description 14
208000024891 symptom Diseases 0.000 description 14
238000002347 injection Methods 0.000 description 13
239000007924 injection Substances 0.000 description 13
230000036961 partial effect Effects 0.000 description 13
238000002965 ELISA Methods 0.000 description 12
239000013604 expression vector Substances 0.000 description 12
230000006870 function Effects 0.000 description 12
230000005714 functional activity Effects 0.000 description 12
230000035772 mutation Effects 0.000 description 12
239000011780 sodium chloride Substances 0.000 description 12
108020004414 DNA Proteins 0.000 description 11
102000018594 Tumour necrosis factor Human genes 0.000 description 11
108050007852 Tumour necrosis factor Proteins 0.000 description 11
238000002474 experimental method Methods 0.000 description 11
230000006872 improvement Effects 0.000 description 11
238000012360 testing method Methods 0.000 description 11
241001465754 Metazoa Species 0.000 description 10
239000011324 bead Substances 0.000 description 10
238000006243 chemical reaction Methods 0.000 description 10
239000003795 chemical substances by application Substances 0.000 description 10
230000009260 cross reactivity Effects 0.000 description 10
102000037865 fusion proteins Human genes 0.000 description 10
108020001507 fusion proteins Proteins 0.000 description 10
239000000126 substance Substances 0.000 description 10
230000001225 therapeutic effect Effects 0.000 description 10
108010021625 Immunoglobulin Fragments Proteins 0.000 description 9
102000008394 Immunoglobulin Fragments Human genes 0.000 description 9
230000009824 affinity maturation Effects 0.000 description 9
208000037976 chronic inflammation Diseases 0.000 description 9
125000003827 glycol group Chemical group 0.000 description 9
210000004072 lung Anatomy 0.000 description 9
241000283707 Capra Species 0.000 description 8
208000019693 Lung disease Diseases 0.000 description 8
241001529936 Murinae Species 0.000 description 8
108010090804 Streptavidin Proteins 0.000 description 8
238000000423 cell based assay Methods 0.000 description 8
231100000135 cytotoxicity Toxicity 0.000 description 8
230000003013 cytotoxicity Effects 0.000 description 8
229940079593 drug Drugs 0.000 description 8
230000002068 genetic effect Effects 0.000 description 8
238000000338 in vitro Methods 0.000 description 8
208000015181 infectious disease Diseases 0.000 description 8
238000007912 intraperitoneal administration Methods 0.000 description 8
238000001990 intravenous administration Methods 0.000 description 8
238000013507 mapping Methods 0.000 description 8
102200077165 rs118204021 Human genes 0.000 description 8
241000282465 Canis Species 0.000 description 7
239000002202 Polyethylene glycol Substances 0.000 description 7
102000007238 Transferrin Receptors Human genes 0.000 description 7
108010033576 Transferrin Receptors Proteins 0.000 description 7
210000004369 blood Anatomy 0.000 description 7
239000008280 blood Substances 0.000 description 7
206010006451 bronchitis Diseases 0.000 description 7
210000004899 c-terminal region Anatomy 0.000 description 7
230000021615 conjugation Effects 0.000 description 7
230000002147 killing effect Effects 0.000 description 7
239000000047 product Substances 0.000 description 7
230000019491 signal transduction Effects 0.000 description 7
241000894007 species Species 0.000 description 7
231100000765 toxin Toxicity 0.000 description 7
239000003053 toxin Substances 0.000 description 7
108010092160 Dactinomycin Proteins 0.000 description 6
102000002812 Heat-Shock Proteins Human genes 0.000 description 6
108010004889 Heat-Shock Proteins Proteins 0.000 description 6
102000007079 Peptide Fragments Human genes 0.000 description 6
108010033276 Peptide Fragments Proteins 0.000 description 6
241000700159 Rattus Species 0.000 description 6
102000004338 Transferrin Human genes 0.000 description 6
108090000901 Transferrin Proteins 0.000 description 6
RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 6
-1 bacteria Chemical class 0.000 description 6
230000009286 beneficial effect Effects 0.000 description 6
230000008901 benefit Effects 0.000 description 6
239000000872 buffer Substances 0.000 description 6
208000037893 chronic inflammatory disorder Diseases 0.000 description 6
238000007918 intramuscular administration Methods 0.000 description 6
238000003752 polymerase chain reaction Methods 0.000 description 6
230000003389 potentiating effect Effects 0.000 description 6
239000000523 sample Substances 0.000 description 6
230000000638 stimulation Effects 0.000 description 6
239000006228 supernatant Substances 0.000 description 6
230000001629 suppression Effects 0.000 description 6
239000012581 transferrin Substances 0.000 description 6
201000008827 tuberculosis Diseases 0.000 description 6
102220471946 Axin interactor, dorsalization-associated protein_H56R_mutation Human genes 0.000 description 5
201000001178 Bacterial Pneumonia Diseases 0.000 description 5
241000282472 Canis lupus familiaris Species 0.000 description 5
206010014561 Emphysema Diseases 0.000 description 5
208000009386 Experimental Arthritis Diseases 0.000 description 5
241000235058 Komagataella pastoris Species 0.000 description 5
206010028980 Neoplasm Diseases 0.000 description 5
108091028043 Nucleic acid sequence Proteins 0.000 description 5
108091034117 Oligonucleotide Proteins 0.000 description 5
238000013459 approach Methods 0.000 description 5
BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 5
239000011230 binding agent Substances 0.000 description 5
239000012228 culture supernatant Substances 0.000 description 5
230000003111 delayed effect Effects 0.000 description 5
230000007124 immune defense Effects 0.000 description 5
108010026228 mRNA guanylyltransferase Proteins 0.000 description 5
238000002844 melting Methods 0.000 description 5
230000008018 melting Effects 0.000 description 5
230000004048 modification Effects 0.000 description 5
238000012986 modification Methods 0.000 description 5
239000006199 nebulizer Substances 0.000 description 5
239000013642 negative control Substances 0.000 description 5
230000008569 process Effects 0.000 description 5
208000023504 respiratory system disease Diseases 0.000 description 5
230000004044 response Effects 0.000 description 5
238000007920 subcutaneous administration Methods 0.000 description 5
238000011830 transgenic mouse model Methods 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
102220470698 BUD13 homolog_V30P_mutation Human genes 0.000 description 4
206010006458 Bronchitis chronic Diseases 0.000 description 4
241000282693 Cercopithecidae Species 0.000 description 4
102000008186 Collagen Human genes 0.000 description 4
108010035532 Collagen Proteins 0.000 description 4
201000003883 Cystic fibrosis Diseases 0.000 description 4
102000004127 Cytokines Human genes 0.000 description 4
108090000695 Cytokines Proteins 0.000 description 4
206010020751 Hypersensitivity Diseases 0.000 description 4
208000010378 Pulmonary Embolism Diseases 0.000 description 4
240000004808 Saccharomyces cerevisiae Species 0.000 description 4
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 4
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 4
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
206010069351 acute lung injury Diseases 0.000 description 4
230000002776 aggregation Effects 0.000 description 4
238000004220 aggregation Methods 0.000 description 4
208000026935 allergic disease Diseases 0.000 description 4
230000002917 arthritic effect Effects 0.000 description 4
229960002685 biotin Drugs 0.000 description 4
239000011616 biotin Substances 0.000 description 4
230000037396 body weight Effects 0.000 description 4
210000000988 bone and bone Anatomy 0.000 description 4
230000015556 catabolic process Effects 0.000 description 4
230000008859 change Effects 0.000 description 4
208000007451 chronic bronchitis Diseases 0.000 description 4
229920001436 collagen Polymers 0.000 description 4
230000001472 cytotoxic effect Effects 0.000 description 4
238000006731 degradation reaction Methods 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
239000010432 diamond Substances 0.000 description 4
239000000539 dimer Substances 0.000 description 4
239000000839 emulsion Substances 0.000 description 4
210000002950 fibroblast Anatomy 0.000 description 4
210000002540 macrophage Anatomy 0.000 description 4
238000005259 measurement Methods 0.000 description 4
230000007246 mechanism Effects 0.000 description 4
238000012544 monitoring process Methods 0.000 description 4
229920001515 polyalkylene glycol Polymers 0.000 description 4
230000000069 prophylactic effect Effects 0.000 description 4
230000002797 proteolythic effect Effects 0.000 description 4
238000000746 purification Methods 0.000 description 4
102200005465 rs121434284 Human genes 0.000 description 4
102220008832 rs193922279 Human genes 0.000 description 4
238000012216 screening Methods 0.000 description 4
231100000617 superantigen Toxicity 0.000 description 4
238000012385 systemic delivery Methods 0.000 description 4
239000013638 trimer Substances 0.000 description 4
102000003298 tumor necrosis factor receptor Human genes 0.000 description 4
239000004474 valine Substances 0.000 description 4
230000003442 weekly effect Effects 0.000 description 4
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 3
102000003966 Alpha-1-microglobulin Human genes 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
101710112752 Cytotoxin Proteins 0.000 description 3
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 3
241000196324 Embryophyta Species 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
108010049003 Fibrinogen Proteins 0.000 description 3
102000008946 Fibrinogen Human genes 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
241000238631 Hexapoda Species 0.000 description 3
241000282412 Homo Species 0.000 description 3
101000930477 Mus musculus Albumin Proteins 0.000 description 3
241001467552 Mycobacterium bovis BCG Species 0.000 description 3
102000016387 Pancreatic elastase Human genes 0.000 description 3
108010067372 Pancreatic elastase Proteins 0.000 description 3
108010019160 Pancreatin Proteins 0.000 description 3
206010057249 Phagocytosis Diseases 0.000 description 3
241000235648 Pichia Species 0.000 description 3
208000025747 Rheumatic disease Diseases 0.000 description 3
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 3
102100039037 Vascular endothelial growth factor A Human genes 0.000 description 3
229930183665 actinomycin Natural products 0.000 description 3
RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 3
239000000556 agonist Substances 0.000 description 3
125000000539 amino acid group Chemical group 0.000 description 3
201000009267 bronchiectasis Diseases 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
230000003833 cell viability Effects 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
230000006020 chronic inflammation Effects 0.000 description 3
230000000295 complement effect Effects 0.000 description 3
238000007796 conventional method Methods 0.000 description 3
231100000433 cytotoxic Toxicity 0.000 description 3
231100000599 cytotoxic agent Toxicity 0.000 description 3
238000002784 cytotoxicity assay Methods 0.000 description 3
231100000263 cytotoxicity test Toxicity 0.000 description 3
239000002619 cytotoxin Substances 0.000 description 3
229960000640 dactinomycin Drugs 0.000 description 3
230000007423 decrease Effects 0.000 description 3
239000008121 dextrose Substances 0.000 description 3
230000029087 digestion Effects 0.000 description 3
208000035475 disorder Diseases 0.000 description 3
238000012377 drug delivery Methods 0.000 description 3
239000012636 effector Substances 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
210000002744 extracellular matrix Anatomy 0.000 description 3
229940012952 fibrinogen Drugs 0.000 description 3
230000009454 functional inhibition Effects 0.000 description 3
230000002496 gastric effect Effects 0.000 description 3
BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 3
210000004602 germ cell Anatomy 0.000 description 3
230000036541 health Effects 0.000 description 3
230000001900 immune effect Effects 0.000 description 3
210000000987 immune system Anatomy 0.000 description 3
229940072221 immunoglobulins Drugs 0.000 description 3
230000006698 induction Effects 0.000 description 3
208000027866 inflammatory disease Diseases 0.000 description 3
206010022000 influenza Diseases 0.000 description 3
210000004185 liver Anatomy 0.000 description 3
239000003550 marker Substances 0.000 description 3
230000035800 maturation Effects 0.000 description 3
238000002703 mutagenesis Methods 0.000 description 3
231100000350 mutagenesis Toxicity 0.000 description 3
230000002018 overexpression Effects 0.000 description 3
229940055695 pancreatin Drugs 0.000 description 3
230000008782 phagocytosis Effects 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
239000013641 positive control Substances 0.000 description 3
238000011533 pre-incubation Methods 0.000 description 3
210000001236 prokaryotic cell Anatomy 0.000 description 3
238000003753 real-time PCR Methods 0.000 description 3
230000008929 regeneration Effects 0.000 description 3
238000011069 regeneration method Methods 0.000 description 3
230000000552 rheumatic effect Effects 0.000 description 3
238000010187 selection method Methods 0.000 description 3
238000001542 size-exclusion chromatography Methods 0.000 description 3
210000003491 skin Anatomy 0.000 description 3
230000009870 specific binding Effects 0.000 description 3
238000012289 standard assay Methods 0.000 description 3
238000010561 standard procedure Methods 0.000 description 3
201000000596 systemic lupus erythematosus Diseases 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
206010001052 Acute respiratory distress syndrome Diseases 0.000 description 2
239000012114 Alexa Fluor 647 Substances 0.000 description 2
101800001761 Alpha-1-microglobulin Proteins 0.000 description 2
206010001881 Alveolar proteinosis Diseases 0.000 description 2
102000005666 Apolipoprotein A-I Human genes 0.000 description 2
108010059886 Apolipoprotein A-I Proteins 0.000 description 2
208000033116 Asbestos intoxication Diseases 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
206010003487 Aspergilloma Diseases 0.000 description 2
108010081589 Becaplermin Proteins 0.000 description 2
206010006049 Bovine Tuberculosis Diseases 0.000 description 2
108010074051 C-Reactive Protein Proteins 0.000 description 2
102100032752 C-reactive protein Human genes 0.000 description 2
OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
108010078791 Carrier Proteins Proteins 0.000 description 2
102000005600 Cathepsins Human genes 0.000 description 2
108010084457 Cathepsins Proteins 0.000 description 2
206010057248 Cell death Diseases 0.000 description 2
102000000503 Collagen Type II Human genes 0.000 description 2
108010041390 Collagen Type II Proteins 0.000 description 2
108010047041 Complementarity Determining Regions Proteins 0.000 description 2
238000001712 DNA sequencing Methods 0.000 description 2
208000018071 Diaphragmatic disease Diseases 0.000 description 2
AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
206010014950 Eosinophilia Diseases 0.000 description 2
208000007530 Essential hypertension Diseases 0.000 description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
108010087819 Fc receptors Proteins 0.000 description 2
102000009109 Fc receptors Human genes 0.000 description 2
102000008857 Ferritin Human genes 0.000 description 2
108050000784 Ferritin Proteins 0.000 description 2
238000008416 Ferritin Methods 0.000 description 2
102100037362 Fibronectin Human genes 0.000 description 2
108010067306 Fibronectins Proteins 0.000 description 2
102000006395 Globulins Human genes 0.000 description 2
108010044091 Globulins Proteins 0.000 description 2
208000009329 Graft vs Host Disease Diseases 0.000 description 2
206010072579 Granulomatosis with polyangiitis Diseases 0.000 description 2
102100036683 Growth arrest-specific protein 1 Human genes 0.000 description 2
102000013271 Hemopexin Human genes 0.000 description 2
108010026027 Hemopexin Proteins 0.000 description 2
101001072723 Homo sapiens Growth arrest-specific protein 1 Proteins 0.000 description 2
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 2
101000595923 Homo sapiens Placenta growth factor Proteins 0.000 description 2
241000714260 Human T-lymphotropic virus 1 Species 0.000 description 2
206010021133 Hypoventilation Diseases 0.000 description 2
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
102100037852 Insulin-like growth factor I Human genes 0.000 description 2
102100039064 Interleukin-3 Human genes 0.000 description 2
108010002386 Interleukin-3 Proteins 0.000 description 2
208000029523 Interstitial Lung disease Diseases 0.000 description 2
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
108010001831 LDL receptors Proteins 0.000 description 2
102100024640 Low-density lipoprotein receptor Human genes 0.000 description 2
206010058467 Lung neoplasm malignant Diseases 0.000 description 2
PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 2
102000009112 Mannose-Binding Lectin Human genes 0.000 description 2
108010087870 Mannose-Binding Lectin Proteins 0.000 description 2
208000029001 Mediastinal disease Diseases 0.000 description 2
241000282520 Papio Species 0.000 description 2
101710176384 Peptide 1 Proteins 0.000 description 2
102100035194 Placenta growth factor Human genes 0.000 description 2
208000002151 Pleural effusion Diseases 0.000 description 2
208000035109 Pneumococcal Infections Diseases 0.000 description 2
241000233870 Pneumocystis Species 0.000 description 2
206010035734 Pneumonia staphylococcal Diseases 0.000 description 2
102000007584 Prealbumin Human genes 0.000 description 2
108010071690 Prealbumin Proteins 0.000 description 2
241000288906 Primates Species 0.000 description 2
108010076504 Protein Sorting Signals Proteins 0.000 description 2
206010037423 Pulmonary oedema Diseases 0.000 description 2
108010025832 RANK Ligand Proteins 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
208000013616 Respiratory Distress Syndrome Diseases 0.000 description 2
206010057190 Respiratory tract infections Diseases 0.000 description 2
206010039085 Rhinitis allergic Diseases 0.000 description 2
206010039491 Sarcoma Diseases 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
230000024932 T cell mediated immunity Effects 0.000 description 2
210000001744 T-lymphocyte Anatomy 0.000 description 2
102100031372 Thymidine phosphorylase Human genes 0.000 description 2
108700023160 Thymidine phosphorylases Proteins 0.000 description 2
101800004564 Transforming growth factor alpha Proteins 0.000 description 2
206010052779 Transplant rejections Diseases 0.000 description 2
102100024568 Tumor necrosis factor ligand superfamily member 11 Human genes 0.000 description 2
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
201000007691 actinomycosis Diseases 0.000 description 2
230000004913 activation Effects 0.000 description 2
208000038016 acute inflammation Diseases 0.000 description 2
230000006022 acute inflammation Effects 0.000 description 2
230000002730 additional effect Effects 0.000 description 2
201000000028 adult respiratory distress syndrome Diseases 0.000 description 2
201000010105 allergic rhinitis Diseases 0.000 description 2
230000007815 allergy Effects 0.000 description 2
108010050122 alpha 1-Antitrypsin Proteins 0.000 description 2
102000015395 alpha 1-Antitrypsin Human genes 0.000 description 2
229940024142 alpha 1-antitrypsin Drugs 0.000 description 2
229960000723 ampicillin Drugs 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
230000003321 amplification Effects 0.000 description 2
238000010171 animal model Methods 0.000 description 2
230000002924 anti-infective effect Effects 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
206010003441 asbestosis Diseases 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
238000012575 bio-layer interferometry Methods 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
230000008499 blood brain barrier function Effects 0.000 description 2
210000001218 blood-brain barrier Anatomy 0.000 description 2
239000002775 capsule Substances 0.000 description 2
230000030833 cell death Effects 0.000 description 2
238000010367 cloning Methods 0.000 description 2
230000001268 conjugating effect Effects 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
238000004132 cross linking Methods 0.000 description 2
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
238000000113 differential scanning calorimetry Methods 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
231100000673 dose–response relationship Toxicity 0.000 description 2
230000009977 dual effect Effects 0.000 description 2
239000000975 dye Substances 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
201000009580 eosinophilic pneumonia Diseases 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
238000013401 experimental design Methods 0.000 description 2
238000005194 fractionation Methods 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
238000002825 functional assay Methods 0.000 description 2
208000024908 graft versus host disease Diseases 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
210000002216 heart Anatomy 0.000 description 2
239000000833 heterodimer Substances 0.000 description 2
239000000710 homodimer Substances 0.000 description 2
230000009610 hypersensitivity Effects 0.000 description 2
208000000122 hyperventilation Diseases 0.000 description 2
230000000870 hyperventilation Effects 0.000 description 2
230000002779 inactivation Effects 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
238000001802 infusion Methods 0.000 description 2
208000014674 injury Diseases 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
229940076264 interleukin-3 Drugs 0.000 description 2
238000001361 intraarterial administration Methods 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
210000001503 joint Anatomy 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
238000011068 loading method Methods 0.000 description 2
201000005202 lung cancer Diseases 0.000 description 2
208000020816 lung neoplasm Diseases 0.000 description 2
239000002609 medium Substances 0.000 description 2
239000012528 membrane Substances 0.000 description 2
229960000485 methotrexate Drugs 0.000 description 2
201000006417 multiple sclerosis Diseases 0.000 description 2
206010028417 myasthenia gravis Diseases 0.000 description 2
230000010807 negative regulation of binding Effects 0.000 description 2
230000003472 neutralizing effect Effects 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
230000000414 obstructive effect Effects 0.000 description 2
239000002245 particle Substances 0.000 description 2
239000013612 plasmid Substances 0.000 description 2
208000024356 pleural disease Diseases 0.000 description 2
206010035653 pneumoconiosis Diseases 0.000 description 2
201000000317 pneumocystosis Diseases 0.000 description 2
239000000843 powder Substances 0.000 description 2
230000017854 proteolysis Effects 0.000 description 2
208000005333 pulmonary edema Diseases 0.000 description 2
201000009732 pulmonary eosinophilia Diseases 0.000 description 2
208000002815 pulmonary hypertension Diseases 0.000 description 2
208000008128 pulmonary tuberculosis Diseases 0.000 description 2
210000003492 pulmonary vein Anatomy 0.000 description 2
RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
238000003127 radioimmunoassay Methods 0.000 description 2
230000006798 recombination Effects 0.000 description 2
238000005215 recombination Methods 0.000 description 2
230000010076 replication Effects 0.000 description 2
108091000053 retinol binding Proteins 0.000 description 2
102000029752 retinol binding Human genes 0.000 description 2
201000000306 sarcoidosis Diseases 0.000 description 2
201000002859 sleep apnea Diseases 0.000 description 2
239000007787 solid Substances 0.000 description 2
238000013223 sprague-dawley female rat Methods 0.000 description 2
208000004048 staphylococcal pneumonia Diseases 0.000 description 2
238000003860 storage Methods 0.000 description 2
239000000725 suspension Substances 0.000 description 2
239000003826 tablet Substances 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 description 2
239000002452 tumor necrosis factor alpha inhibitor Substances 0.000 description 2
208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 2
125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
239000003981 vehicle Substances 0.000 description 2
KUHSEZKIEJYEHN-BXRBKJIMSA-N (2s)-2-amino-3-hydroxypropanoic acid;(2s)-2-aminopropanoic acid Chemical compound C[C@H](N)C(O)=O.OC[C@H](N)C(O)=O KUHSEZKIEJYEHN-BXRBKJIMSA-N 0.000 description 1
NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 description 1
KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 1
APRZHQXAAWPYHS-UHFFFAOYSA-N 4-[5-[3-(carboxymethoxy)phenyl]-3-(4,5-dimethyl-1,3-thiazol-2-yl)tetrazol-3-ium-2-yl]benzenesulfonate Chemical compound S1C(C)=C(C)N=C1[N+]1=NC(C=2C=C(OCC(O)=O)C=CC=2)=NN1C1=CC=C(S([O-])(=O)=O)C=C1 APRZHQXAAWPYHS-UHFFFAOYSA-N 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
101150016901 ALB1 gene Proteins 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
102100022987 Angiogenin Human genes 0.000 description 1
235000002198 Annona diversifolia Nutrition 0.000 description 1
102000004411 Antithrombin III Human genes 0.000 description 1
108090000935 Antithrombin III Proteins 0.000 description 1
101710095342 Apolipoprotein B Proteins 0.000 description 1
102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
102100040214 Apolipoprotein(a) Human genes 0.000 description 1
101100274294 Arabidopsis thaliana CHLD gene Proteins 0.000 description 1
241000228257 Aspergillus sp. Species 0.000 description 1
201000001320 Atherosclerosis Diseases 0.000 description 1
241000193738 Bacillus anthracis Species 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
102100037437 Beta-defensin 1 Human genes 0.000 description 1
101710125314 Beta-defensin 1 Proteins 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
108010049976 Bone Morphogenetic Protein 5 Proteins 0.000 description 1
108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 description 1
108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 1
102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
102100022526 Bone morphogenetic protein 5 Human genes 0.000 description 1
102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 1
208000014181 Bronchial disease Diseases 0.000 description 1
108010021064 CTLA-4 Antigen Proteins 0.000 description 1
102000008203 CTLA-4 Antigen Human genes 0.000 description 1
229940045513 CTLA4 antagonist Drugs 0.000 description 1
101100180402 Caenorhabditis elegans jun-1 gene Proteins 0.000 description 1
241000282832 Camelidae Species 0.000 description 1
241000282836 Camelus dromedarius Species 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
108010075016 Ceruloplasmin Proteins 0.000 description 1
102100023321 Ceruloplasmin Human genes 0.000 description 1
108010078239 Chemokine CX3CL1 Proteins 0.000 description 1
241000251730 Chondrichthyes Species 0.000 description 1
101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
102000004266 Collagen Type IV Human genes 0.000 description 1
108010042086 Collagen Type IV Proteins 0.000 description 1
108700040183 Complement C1 Inhibitor Proteins 0.000 description 1
102000055157 Complement C1 Inhibitor Human genes 0.000 description 1
206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
108010036949 Cyclosporine Proteins 0.000 description 1
108010061642 Cystatin C Proteins 0.000 description 1
102000012192 Cystatin C Human genes 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
102000052510 DNA-Binding Proteins Human genes 0.000 description 1
101710096438 DNA-binding protein Proteins 0.000 description 1
101150082070 Dab gene Proteins 0.000 description 1
108010002069 Defensins Proteins 0.000 description 1
102000000541 Defensins Human genes 0.000 description 1
208000034423 Delivery Diseases 0.000 description 1
208000016192 Demyelinating disease Diseases 0.000 description 1
208000018672 Dilatation Diseases 0.000 description 1
201000010046 Dilated cardiomyopathy Diseases 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
206010015866 Extravasation Diseases 0.000 description 1
108010014173 Factor X Proteins 0.000 description 1
102000009123 Fibrin Human genes 0.000 description 1
108010073385 Fibrin Proteins 0.000 description 1
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
241000724791 Filamentous phage Species 0.000 description 1
102100020997 Fractalkine Human genes 0.000 description 1
108091006027 G proteins Proteins 0.000 description 1
102000030782 GTP binding Human genes 0.000 description 1
108091000058 GTP-Binding Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
108010053070 Glutathione Disulfide Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
101150009006 HIS3 gene Proteins 0.000 description 1
108010045100 HSP27 Heat-Shock Proteins Proteins 0.000 description 1
102100039165 Heat shock protein beta-1 Human genes 0.000 description 1
102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 description 1
101000780591 Homo sapiens AFG3-like protein 2 Proteins 0.000 description 1
101001045751 Homo sapiens Hepatocyte nuclear factor 1-alpha Proteins 0.000 description 1
101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 1
101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 1
101001013648 Homo sapiens Methionine synthase Proteins 0.000 description 1
101000797623 Homo sapiens Protein AMBP Proteins 0.000 description 1
101000841411 Homo sapiens Protein ecdysoneless homolog Proteins 0.000 description 1
201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 1
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
102000013463 Immunoglobulin Light Chains Human genes 0.000 description 1
108010065825 Immunoglobulin Light Chains Proteins 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102000003746 Insulin Receptor Human genes 0.000 description 1
108010001127 Insulin Receptor Proteins 0.000 description 1
102100025947 Insulin-like growth factor II Human genes 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
108010076876 Keratins Proteins 0.000 description 1
102000011782 Keratins Human genes 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
241000282838 Lama Species 0.000 description 1
241000282852 Lama guanicoe Species 0.000 description 1
102000007547 Laminin Human genes 0.000 description 1
108010085895 Laminin Proteins 0.000 description 1
206010065048 Latent tuberculosis Diseases 0.000 description 1
102000019298 Lipocalin Human genes 0.000 description 1
108050006654 Lipocalin Proteins 0.000 description 1
108010033266 Lipoprotein(a) Proteins 0.000 description 1
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
102000004378 Melanocortin Receptors Human genes 0.000 description 1
108090000950 Melanocortin Receptors Proteins 0.000 description 1
206010027406 Mesothelioma Diseases 0.000 description 1
102000005741 Metalloproteases Human genes 0.000 description 1
108010006035 Metalloproteases Proteins 0.000 description 1
102100030335 Midkine Human genes 0.000 description 1
108010092801 Midkine Proteins 0.000 description 1
101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
101100434646 Mus musculus Alb gene Proteins 0.000 description 1
101100288142 Mus musculus Klkb1 gene Proteins 0.000 description 1
102000047918 Myelin Basic Human genes 0.000 description 1
102000006386 Myelin Proteins Human genes 0.000 description 1
108010083674 Myelin Proteins Proteins 0.000 description 1
101710107068 Myelin basic protein Proteins 0.000 description 1
102100030856 Myoglobin Human genes 0.000 description 1
108010062374 Myoglobin Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
206010028851 Necrosis Diseases 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
108010015098 Nerve Tissue Proteins Proteins 0.000 description 1
102000001739 Nerve Tissue Proteins Human genes 0.000 description 1
241000221961 Neurospora crassa Species 0.000 description 1
102400001060 Neutrophil defensin 2 Human genes 0.000 description 1
101710117153 Neutrophil defensin 2 Proteins 0.000 description 1
102100024761 Neutrophil defensin 3 Human genes 0.000 description 1
101710117152 Neutrophil defensin 3 Proteins 0.000 description 1
244000061176 Nicotiana tabacum Species 0.000 description 1
235000002637 Nicotiana tabacum Nutrition 0.000 description 1
241001452677 Ogataea methanolica Species 0.000 description 1
102000007990 Organic Anion Transporters Human genes 0.000 description 1
108010089503 Organic Anion Transporters Proteins 0.000 description 1
108010061952 Orosomucoid Proteins 0.000 description 1
102000012404 Orosomucoid Human genes 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
101710126321 Pancreatic trypsin inhibitor Proteins 0.000 description 1
241001504519 Papio ursinus Species 0.000 description 1
108010051456 Plasminogen Proteins 0.000 description 1
102000013566 Plasminogen Human genes 0.000 description 1
206010035667 Pneumonia anthrax Diseases 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
102000011195 Profilin Human genes 0.000 description 1
108050001408 Profilin Proteins 0.000 description 1
201000001263 Psoriatic Arthritis Diseases 0.000 description 1
208000036824 Psoriatic arthropathy Diseases 0.000 description 1
238000011529 RT qPCR Methods 0.000 description 1
101000930457 Rattus norvegicus Albumin Proteins 0.000 description 1
101100288143 Rattus norvegicus Klkb1 gene Proteins 0.000 description 1
101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
241000714474 Rous sarcoma virus Species 0.000 description 1
241000235347 Schizosaccharomyces pombe Species 0.000 description 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
206010040070 Septic Shock Diseases 0.000 description 1
108700028909 Serum Amyloid A Proteins 0.000 description 1
102000054727 Serum Amyloid A Human genes 0.000 description 1
241000295644 Staphylococcaceae Species 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
108010085004 TGF-beta Superfamily Proteins Proteins 0.000 description 1
102000007453 TGF-beta Superfamily Proteins Human genes 0.000 description 1
108010004408 TRPP Cation Channels Proteins 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
108010022394 Threonine synthase Proteins 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
102000006747 Transforming Growth Factor alpha Human genes 0.000 description 1
102400001320 Transforming growth factor alpha Human genes 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 1
101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
102000044159 Ubiquitin Human genes 0.000 description 1
108090000848 Ubiquitin Proteins 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
241001416177 Vicugna pacos Species 0.000 description 1
241000700605 Viruses Species 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
229940009456 adriamycin Drugs 0.000 description 1
239000004479 aerosol dispenser Substances 0.000 description 1
230000008484 agonism Effects 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
108010091628 alpha 1-Antichymotrypsin Proteins 0.000 description 1
230000002491 angiogenic effect Effects 0.000 description 1
108010072788 angiogenin Proteins 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
102000025171 antigen binding proteins Human genes 0.000 description 1
108091000831 antigen binding proteins Proteins 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
229960005348 antithrombin iii Drugs 0.000 description 1
229940072107 ascorbate Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
238000002819 bacterial display Methods 0.000 description 1
108010081355 beta 2-Microglobulin Proteins 0.000 description 1
102000015736 beta 2-Microglobulin Human genes 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
238000002306 biochemical method Methods 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
238000013378 biophysical characterization Methods 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
210000004781 brain capillary Anatomy 0.000 description 1
210000000621 bronchi Anatomy 0.000 description 1
229940009550 c1 esterase inhibitor Drugs 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
239000000969 carrier Substances 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
108091092356 cellular DNA Proteins 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
239000003541 chymotrypsin inhibitor Substances 0.000 description 1
229960001265 ciclosporin Drugs 0.000 description 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
229960004316 cisplatin Drugs 0.000 description 1
238000011260 co-administration Methods 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
238000012875 competitive assay Methods 0.000 description 1
230000006957 competitive inhibition Effects 0.000 description 1
230000024203 complement activation Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
210000004087 cornea Anatomy 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
229930182912 cyclosporin Natural products 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
239000000032 diagnostic agent Substances 0.000 description 1
229940039227 diagnostic agent Drugs 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
230000009699 differential effect Effects 0.000 description 1
102000004419 dihydrofolate reductase Human genes 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
238000011143 downstream manufacturing Methods 0.000 description 1
229940112141 dry powder inhaler Drugs 0.000 description 1
238000001378 electrochemiluminescence detection Methods 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
230000002996 emotional effect Effects 0.000 description 1
230000008519 endogenous mechanism Effects 0.000 description 1
210000001163 endosome Anatomy 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
231100000655 enterotoxin Toxicity 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
102000015694 estrogen receptors Human genes 0.000 description 1
108010038795 estrogen receptors Proteins 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
230000036251 extravasation Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
229950003499 fibrin Drugs 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000001917 fluorescence detection Methods 0.000 description 1
101150054895 ftsH gene Proteins 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000001641 gel filtration chromatography Methods 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
150000002334 glycols Chemical class 0.000 description 1
230000033687 granuloma formation Effects 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
229940022353 herceptin Drugs 0.000 description 1
102000054037 human AFG3L2 Human genes 0.000 description 1
102000047791 human ECD Human genes 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
230000036039 immunity Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
239000002955 immunomodulating agent Substances 0.000 description 1
238000009169 immunotherapy Methods 0.000 description 1
239000002596 immunotoxin Substances 0.000 description 1
231100000608 immunotoxin Toxicity 0.000 description 1
230000002637 immunotoxin Effects 0.000 description 1
229940051026 immunotoxin Drugs 0.000 description 1
239000012535 impurity Substances 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
208000009449 inhalation anthrax Diseases 0.000 description 1
208000023372 inhalational anthrax Diseases 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000002608 insulinlike Effects 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
230000003993 interaction Effects 0.000 description 1
208000036971 interstitial lung disease 2 Diseases 0.000 description 1
230000003871 intestinal function Effects 0.000 description 1
208000018937 joint inflammation Diseases 0.000 description 1
230000000366 juvenile effect Effects 0.000 description 1
210000003041 ligament Anatomy 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
229940071648 metered dose inhaler Drugs 0.000 description 1
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
230000004001 molecular interaction Effects 0.000 description 1
239000003068 molecular probe Substances 0.000 description 1
230000000921 morphogenic effect Effects 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
238000000569 multi-angle light scattering Methods 0.000 description 1
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
229960000951 mycophenolic acid Drugs 0.000 description 1
210000005012 myelin Anatomy 0.000 description 1
230000017074 necrotic cell death Effects 0.000 description 1
230000011234 negative regulation of signal transduction Effects 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
210000000944 nerve tissue Anatomy 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
210000003458 notochord Anatomy 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
230000001991 pathophysiological effect Effects 0.000 description 1
230000006320 pegylation Effects 0.000 description 1
210000001322 periplasm Anatomy 0.000 description 1
238000002823 phage display Methods 0.000 description 1
239000006187 pill Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
230000004983 pleiotropic effect Effects 0.000 description 1
229920001748 polybutylene Polymers 0.000 description 1
229920000098 polyolefin Polymers 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
210000004896 polypeptide structure Anatomy 0.000 description 1
229920001451 polypropylene glycol Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000007639 printing Methods 0.000 description 1
238000012545 processing Methods 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
238000002818 protein evolution Methods 0.000 description 1
210000004879 pulmonary tissue Anatomy 0.000 description 1
229950010131 puromycin Drugs 0.000 description 1
238000011002 quantification Methods 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
230000007420 reactivation Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
208000020029 respiratory tract infectious disease Diseases 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
238000002702 ribosome display Methods 0.000 description 1
238000013391 scatchard analysis Methods 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
229910052711 selenium Inorganic materials 0.000 description 1
239000011669 selenium Substances 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
230000036303 septic shock Effects 0.000 description 1
238000004513 sizing Methods 0.000 description 1
230000000391 smoking effect Effects 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
239000001540 sodium lactate Substances 0.000 description 1
229940005581 sodium lactate Drugs 0.000 description 1
235000011088 sodium lactate Nutrition 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
230000001839 systemic circulation Effects 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
230000008685 targeting Effects 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
101150118377 tet gene Proteins 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
206010043778 thyroiditis Diseases 0.000 description 1
238000004448 titration Methods 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
230000037317 transdermal delivery Effects 0.000 description 1
230000026683 transduction Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
102000027257 transmembrane receptors Human genes 0.000 description 1
108091008578 transmembrane receptors Proteins 0.000 description 1
230000032258 transport Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
210000002993 trophoblast Anatomy 0.000 description 1
230000006433 tumor necrosis factor production Effects 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
230000009677 vaginal delivery Effects 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
210000001835 viscera Anatomy 0.000 description 1
210000004127 vitreous body Anatomy 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1